Sahajanand Medical Technologies IPO makes debut with 7.9% premium at ₹371 apiece on the NSE

Sahajanand Medical Technologies shares made a strong debut on the bourses on Friday, listing at a 7.9% premium to the issue price. The issue received a stellar response from investors, with a 14.2x oversubscription. The IPO was an entirely offer-for-sale of ₹475 crore. The IPO bidding started on October 15 and ended on October 19, and the allotment was finalised on October 21.

Sahajanand Medical Technologies listing price

The shares got listed at ₹373, delivering a premium of 7.9% against the issue price of ₹344 apiece. The allottees received 43 shares each against the one-lot application.

Subscription stats

The overall IPO secured a robust response from the full set of investors during the issue. The QIB category was oversubscribed by 34x after receiving bids for 9.4 crore shares against 27 lakh offered for the category. Similarly, the NII category received bids for 2.98 crore shares against 20.3 lakh shares offered. The retail category secured bids for 1.4 crore shares against 47.5 lakh shares offered.

About Sahajanand Medical Technologies

Incorporated in 2001, the company is engaged in developing, manufacturing, and marketing medical devices, primarily focused on vascular interventions and structural heart interventions. The company makes products like coronary stents, coronary balloons, and renal stents, among others. The company has two manufacturing plants in India and one in Thailand, and two Research & Development (R&D) facilities in India and Thailand.

(This is a developing story